Clinical trial
A Randomized Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions (DECODE)
NCT00489164 is registered in ClinicalTrials.gov with Cordis US Corp. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions (DECODE)
- Lead sponsor
- Cordis US Corp.
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- August 31, 2002
- Completion date
- May 31, 2004
- Enrollment
- 83 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.